Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017

WOBURN, Mass., Dec. 07, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CSO Kristi Snell, Ph.D., will be presenting today on a panel being held at the CanolaWeek 2017 conference.  Dr. Snell’s presentation is titled “Technology for increasing seed yield and oil content in oilseed crops” and is taking place on a panel scheduled from 1:00 to 2:30 pm local time as part of the Canola Innovation Day program. CanolaWeek 2017, sponsored by the Canola Council of Canada and Ag-West Bio, Inc., is being held December 5-7, 2017 in Saskatoon, SK, Canada.

In the presentation, Dr. Snell will highlight the approach Yield10 and its wholly owned Canadian subsidiary, Metabolix Oilseeds, are taking to increase seed yield and oil content in oilseed crops, including canola. She will discuss ongoing research with C3003, an algal gene Yield10 is deploying as a novel yield trait for C3 photosynthetic crops including Camelina, canola, soybean and rice.  Data from Yield10 suggests that C3003 may provide an entirely new strategy to improve seed yield by bringing in new metabolic functionality from non-plant systems. In addition, she will also describe the design and development of new traits for improving oil content based on genome editing approaches to drive increases in oil biosynthesis.

Learn more about the Conference at CanolaWeek2017.  A copy of Dr. Snell’s slide deck will be available at 2:00pm ET on the Yield10 Bioscience website. 

About Yield10 Bioscience

Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems.  Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and rice. Yield10 is headquartered in Woburn, MA and has an Oilseeds center of excellence, Metabolix Oilseeds, in Saskatoon, Canada. 

For more information about the Company, please visit www.yield10bio.com.

(YTEN-G)

Safe Harbor for Forward-Looking Statements  

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, the potential for new plants to be classified as “nonregulated” and for rapid commercialization of new traits in crops using these technologies, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in Yield10 Bioscience's filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.

Contacts: 
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, [email protected]

Investor Relations Contact: 
Amato and Partners, LLC
90 Park Avenue, 17^th Floor
New York, NY 10016
[email protected]